目次

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market by Geography
Exhibit 05: Executive Summary - Chart on Market Segmentation by Product
Exhibit 06: Executive Summary - Chart on Market Segmentation by Type
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size
4.1 Global anti-CD20 monoclonal antibodies (mABs) market 2018 - 2022
Exhibit 18: Historic Market Size - Data Table on global anti-cd20 monoclonal antibodies (mabs) market 2018 - 2022 ($ million)
4.2 Product Segment Analysis 2018 - 2022
Exhibit 19: Historic Market Size - Product Segment 2018 - 2022 ($ million)
4.3 Type Segment Analysis 2018 - 2022
Exhibit 20: Historic Market Size - Type Segment 2018 - 2022 ($ million)
4.4 Geography Segment Analysis 2018 - 2022
Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.5 Country Segment Analysis 2018 - 2022
Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Product
6.1 Market segments
Exhibit 30: Chart on Product - Market share 2023-2028 (%)
Exhibit 31: Data Table on Product - Market share 2023-2028 (%)
6.2 Comparison by Product
Exhibit 32: Chart on Comparison by Product
Exhibit 33: Data Table on Comparison by Product
6.3 Oncology - Market size and forecast 2023-2028
Exhibit 34: Chart on Oncology - Market size and forecast 2023-2028 ($ million)
Exhibit 35: Data Table on Oncology - Market size and forecast 2023-2028 ($ million)
Exhibit 36: Chart on Oncology - Year-over-year growth 2023-2028 (%)
Exhibit 37: Data Table on Oncology - Year-over-year growth 2023-2028 (%)
6.4 Neurology - Market size and forecast 2023-2028
Exhibit 38: Chart on Neurology - Market size and forecast 2023-2028 ($ million)
Exhibit 39: Data Table on Neurology - Market size and forecast 2023-2028 ($ million)
Exhibit 40: Chart on Neurology - Year-over-year growth 2023-2028 (%)
Exhibit 41: Data Table on Neurology - Year-over-year growth 2023-2028 (%)
6.5 Immunology - Market size and forecast 2023-2028
Exhibit 42: Chart on Immunology - Market size and forecast 2023-2028 ($ million)
Exhibit 43: Data Table on Immunology - Market size and forecast 2023-2028 ($ million)
Exhibit 44: Chart on Immunology - Year-over-year growth 2023-2028 (%)
Exhibit 45: Data Table on Immunology - Year-over-year growth 2023-2028 (%)
6.6 Market opportunity by Product
Exhibit 46: Market opportunity by Product ($ million)
Exhibit 47: Data Table on Market opportunity by Product ($ million)

7 Market Segmentation by Type
7.1 Market segments
Exhibit 48: Chart on Type - Market share 2023-2028 (%)
Exhibit 49: Data Table on Type - Market share 2023-2028 (%)
7.2 Comparison by Type
Exhibit 50: Chart on Comparison by Type
Exhibit 51: Data Table on Comparison by Type
7.3 First generation anti-CD20 monoclonal antibody - Market size and forecast 2023-2028
Exhibit 52: Chart on First generation anti-CD20 monoclonal antibody - Market size and forecast 2023-2028 ($ million)
Exhibit 53: Data Table on First generation anti-CD20 monoclonal antibody - Market size and forecast 2023-2028 ($ million)
Exhibit 54: Chart on First generation anti-CD20 monoclonal antibody - Year-over-year growth 2023-2028 (%)
Exhibit 55: Data Table on First generation anti-CD20 monoclonal antibody - Year-over-year growth 2023-2028 (%)
7.4 Second generation anti-CD20 monoclonal antibody - Market size and forecast 2023-2028
Exhibit 56: Chart on Second generation anti-CD20 monoclonal antibody - Market size and forecast 2023-2028 ($ million)
Exhibit 57: Data Table on Second generation anti-CD20 monoclonal antibody - Market size and forecast 2023-2028 ($ million)
Exhibit 58: Chart on Second generation anti-CD20 monoclonal antibody - Year-over-year growth 2023-2028 (%)
Exhibit 59: Data Table on Second generation anti-CD20 monoclonal antibody - Year-over-year growth 2023-2028 (%)
7.5 Third generation anti-CD20 monoclonal antibody - Market size and forecast 2023-2028
Exhibit 60: Chart on Third generation anti-CD20 monoclonal antibody - Market size and forecast 2023-2028 ($ million)
Exhibit 61: Data Table on Third generation anti-CD20 monoclonal antibody - Market size and forecast 2023-2028 ($ million)
Exhibit 62: Chart on Third generation anti-CD20 monoclonal antibody - Year-over-year growth 2023-2028 (%)
Exhibit 63: Data Table on Third generation anti-CD20 monoclonal antibody - Year-over-year growth 2023-2028 (%)
7.6 Market opportunity by Type
Exhibit 64: Market opportunity by Type ($ million)
Exhibit 65: Data Table on Market opportunity by Type ($ million)

8 Customer Landscape
8.1 Customer landscape overview
Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 67: Chart on Market share by geography 2023-2028 (%)
Exhibit 68: Data Table on Market share by geography 2023-2028 (%)
9.2 Geographic comparison
Exhibit 69: Chart on Geographic comparison
Exhibit 70: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Exhibit 71: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibit 72: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibit 73: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibit 74: Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
Exhibit 75: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibit 76: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibit 77: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibit 78: Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
Exhibit 79: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibit 80: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibit 81: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibit 82: Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Exhibit 83: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibit 84: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibit 85: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibit 86: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Exhibit 87: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibit 88: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibit 89: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibit 90: Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 Canada - Market size and forecast 2023-2028
Exhibit 91: Chart on Canada - Market size and forecast 2023-2028 ($ million)
Exhibit 92: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Exhibit 93: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibit 94: Data Table on Canada - Year-over-year growth 2023-2028 (%)
9.9 Germany - Market size and forecast 2023-2028
Exhibit 95: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibit 96: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibit 97: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibit 98: Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.10 UK - Market size and forecast 2023-2028
Exhibit 99: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibit 100: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibit 101: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibit 102: Data Table on UK - Year-over-year growth 2023-2028 (%)
9.11 China - Market size and forecast 2023-2028
Exhibit 103: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibit 104: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibit 105: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibit 106: Data Table on China - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity by geography
Exhibit 107: Market opportunity by geography ($ million)
Exhibit 108: Data Tables on Market opportunity by geography ($ million)

10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 109: Impact of drivers and challenges in 2023 and 2028
10.4 Market trends

11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 110: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 111: Overview on factors of disruption
11.4 Industry risks
Exhibit 112: Impact of key risks on business

12 Vendor Analysis
12.1 Vendors covered
Exhibit 113: Vendors covered
12.2 Market positioning of vendors
Exhibit 114: Matrix on vendor position and classification
12.3 Acrotech Biopharma Inc.
Exhibit 115: Acrotech Biopharma Inc. - Overview
Exhibit 116: Acrotech Biopharma Inc. - Product / Service
Exhibit 117: Acrotech Biopharma Inc. - Key offerings
12.4 Amgen Inc.
Exhibit 118: Amgen Inc. - Overview
Exhibit 119: Amgen Inc. - Product / Service
Exhibit 120: Amgen Inc. - Key offerings
12.5 AstraZeneca Plc
Exhibit 121: AstraZeneca Plc - Overview
Exhibit 122: AstraZeneca Plc - Product / Service
Exhibit 123: AstraZeneca Plc - Key news
Exhibit 124: AstraZeneca Plc - Key offerings
12.6 Celltrion Healthcare Co. Ltd.
Exhibit 125: Celltrion Healthcare Co. Ltd. - Overview
Exhibit 126: Celltrion Healthcare Co. Ltd. - Product / Service
Exhibit 127: Celltrion Healthcare Co. Ltd. - Key offerings
12.7 F. Hoffmann La Roche Ltd.
Exhibit 128: F. Hoffmann La Roche Ltd. - Overview
Exhibit 129: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 130: F. Hoffmann La Roche Ltd. - Key news
Exhibit 131: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 132: F. Hoffmann La Roche Ltd. - Segment focus
12.8 Fosun International Ltd.
Exhibit 133: Fosun International Ltd. - Overview
Exhibit 134: Fosun International Ltd. - Product / Service
Exhibit 135: Fosun International Ltd. - Key offerings
12.9 Genmab AS
Exhibit 136: Genmab AS - Overview
Exhibit 137: Genmab AS - Key offerings
12.10 IGM Biosciences Inc.
Exhibit 138: IGM Biosciences Inc. - Overview
Exhibit 139: IGM Biosciences Inc. - Product / Service
Exhibit 140: IGM Biosciences Inc. - Key offerings
12.11 JSC BIOCAD
Exhibit 141: JSC BIOCAD - Overview
Exhibit 142: JSC BIOCAD - Product / Service
Exhibit 143: JSC BIOCAD - Key offerings
12.12 LFB SA
Exhibit 144: LFB SA - Overview
Exhibit 145: LFB SA - Product / Service
Exhibit 146: LFB SA - Key offerings
12.13 Novartis AG
Exhibit 147: Novartis AG - Overview
Exhibit 148: Novartis AG - Business segments
Exhibit 149: Novartis AG - Key offerings
Exhibit 150: Novartis AG - Segment focus
12.14 Pfizer Inc.
Exhibit 151: Pfizer Inc. - Overview
Exhibit 152: Pfizer Inc. - Product / Service
Exhibit 153: Pfizer Inc. - Key news
Exhibit 154: Pfizer Inc. - Key offerings
12.15 Regeneron Pharmaceuticals Inc.
Exhibit 155: Regeneron Pharmaceuticals Inc. - Overview
Exhibit 156: Regeneron Pharmaceuticals Inc. - Product / Service
Exhibit 157: Regeneron Pharmaceuticals Inc. - Key offerings
12.16 Spectrum Pharmaceuticals Inc.
Exhibit 158: Spectrum Pharmaceuticals Inc. - Overview
Exhibit 159: Spectrum Pharmaceuticals Inc. - Product / Service
Exhibit 160: Spectrum Pharmaceuticals Inc. - Key offerings
12.17 TG Therapeutics Inc.
Exhibit 161: TG Therapeutics Inc. - Overview
Exhibit 162: TG Therapeutics Inc. - Product / Service
Exhibit 163: TG Therapeutics Inc. - Key offerings

13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 164: Inclusions checklist
Exhibit 165: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 166: Currency conversion rates for US$
13.4 Research methodology
Exhibit 167: Research methodology
Exhibit 168: Validation techniques employed for market sizing
Exhibit 169: Information sources
13.5 List of abbreviations
Exhibit 170: List of abbreviations

Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market by Geography
Exhibits5: Executive Summary - Chart on Market Segmentation by Product
Exhibits6: Executive Summary - Chart on Market Segmentation by Type
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits18: Historic Market Size - Data Table on global anti-cd20 monoclonal antibodies (mabs) market 2018 - 2022 ($ million)
Exhibits19: Historic Market Size - Product Segment 2018 - 2022 ($ million)
Exhibits20: Historic Market Size - Type Segment 2018 - 2022 ($ million)
Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
Exhibits23: Five forces analysis - Comparison between 2023 and 2028
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits29: Chart on Market condition - Five forces 2023 and 2028
Exhibits30: Chart on Product - Market share 2023-2028 (%)
Exhibits31: Data Table on Product - Market share 2023-2028 (%)
Exhibits32: Chart on Comparison by Product
Exhibits33: Data Table on Comparison by Product
Exhibits34: Chart on Oncology - Market size and forecast 2023-2028 ($ million)
Exhibits35: Data Table on Oncology - Market size and forecast 2023-2028 ($ million)
Exhibits36: Chart on Oncology - Year-over-year growth 2023-2028 (%)
Exhibits37: Data Table on Oncology - Year-over-year growth 2023-2028 (%)
Exhibits38: Chart on Neurology - Market size and forecast 2023-2028 ($ million)
Exhibits39: Data Table on Neurology - Market size and forecast 2023-2028 ($ million)
Exhibits40: Chart on Neurology - Year-over-year growth 2023-2028 (%)
Exhibits41: Data Table on Neurology - Year-over-year growth 2023-2028 (%)
Exhibits42: Chart on Immunology - Market size and forecast 2023-2028 ($ million)
Exhibits43: Data Table on Immunology - Market size and forecast 2023-2028 ($ million)
Exhibits44: Chart on Immunology - Year-over-year growth 2023-2028 (%)
Exhibits45: Data Table on Immunology - Year-over-year growth 2023-2028 (%)
Exhibits46: Market opportunity by Product ($ million)
Exhibits47: Data Table on Market opportunity by Product ($ million)
Exhibits48: Chart on Type - Market share 2023-2028 (%)
Exhibits49: Data Table on Type - Market share 2023-2028 (%)
Exhibits50: Chart on Comparison by Type
Exhibits51: Data Table on Comparison by Type
Exhibits52: Chart on First generation anti-CD20 monoclonal antibody - Market size and forecast 2023-2028 ($ million)
Exhibits53: Data Table on First generation anti-CD20 monoclonal antibody - Market size and forecast 2023-2028 ($ million)
Exhibits54: Chart on First generation anti-CD20 monoclonal antibody - Year-over-year growth 2023-2028 (%)
Exhibits55: Data Table on First generation anti-CD20 monoclonal antibody - Year-over-year growth 2023-2028 (%)
Exhibits56: Chart on Second generation anti-CD20 monoclonal antibody - Market size and forecast 2023-2028 ($ million)
Exhibits57: Data Table on Second generation anti-CD20 monoclonal antibody - Market size and forecast 2023-2028 ($ million)
Exhibits58: Chart on Second generation anti-CD20 monoclonal antibody - Year-over-year growth 2023-2028 (%)
Exhibits59: Data Table on Second generation anti-CD20 monoclonal antibody - Year-over-year growth 2023-2028 (%)
Exhibits60: Chart on Third generation anti-CD20 monoclonal antibody - Market size and forecast 2023-2028 ($ million)
Exhibits61: Data Table on Third generation anti-CD20 monoclonal antibody - Market size and forecast 2023-2028 ($ million)
Exhibits62: Chart on Third generation anti-CD20 monoclonal antibody - Year-over-year growth 2023-2028 (%)
Exhibits63: Data Table on Third generation anti-CD20 monoclonal antibody - Year-over-year growth 2023-2028 (%)
Exhibits64: Market opportunity by Type ($ million)
Exhibits65: Data Table on Market opportunity by Type ($ million)
Exhibits66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits67: Chart on Market share by geography 2023-2028 (%)
Exhibits68: Data Table on Market share by geography 2023-2028 (%)
Exhibits69: Chart on Geographic comparison
Exhibits70: Data Table on Geographic comparison
Exhibits71: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibits72: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibits73: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits74: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits75: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits76: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits77: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits78: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits79: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits80: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits81: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits82: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits83: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits84: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits85: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits86: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits87: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibits88: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibits89: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits90: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits91: Chart on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits92: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits93: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibits94: Data Table on Canada - Year-over-year growth 2023-2028 (%)
Exhibits95: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits96: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits97: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits98: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits99: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibits100: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibits101: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits102: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits103: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibits104: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibits105: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits106: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits107: Market opportunity by geography ($ million)
Exhibits108: Data Tables on Market opportunity by geography ($ million)
Exhibits109: Impact of drivers and challenges in 2023 and 2028
Exhibits110: Overview on Criticality of inputs and Factors of differentiation
Exhibits111: Overview on factors of disruption
Exhibits112: Impact of key risks on business
Exhibits113: Vendors covered
Exhibits114: Matrix on vendor position and classification
Exhibits115: Acrotech Biopharma Inc. - Overview
Exhibits116: Acrotech Biopharma Inc. - Product / Service
Exhibits117: Acrotech Biopharma Inc. - Key offerings
Exhibits118: Amgen Inc. - Overview
Exhibits119: Amgen Inc. - Product / Service
Exhibits120: Amgen Inc. - Key offerings
Exhibits121: AstraZeneca Plc - Overview
Exhibits122: AstraZeneca Plc - Product / Service
Exhibits123: AstraZeneca Plc - Key news
Exhibits124: AstraZeneca Plc - Key offerings
Exhibits125: Celltrion Healthcare Co. Ltd. - Overview
Exhibits126: Celltrion Healthcare Co. Ltd. - Product / Service
Exhibits127: Celltrion Healthcare Co. Ltd. - Key offerings
Exhibits128: F. Hoffmann La Roche Ltd. - Overview
Exhibits129: F. Hoffmann La Roche Ltd. - Business segments
Exhibits130: F. Hoffmann La Roche Ltd. - Key news
Exhibits131: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits132: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits133: Fosun International Ltd. - Overview
Exhibits134: Fosun International Ltd. - Product / Service
Exhibits135: Fosun International Ltd. - Key offerings
Exhibits136: Genmab AS - Overview
Exhibits137: Genmab AS - Key offerings
Exhibits138: IGM Biosciences Inc. - Overview
Exhibits139: IGM Biosciences Inc. - Product / Service
Exhibits140: IGM Biosciences Inc. - Key offerings
Exhibits141: JSC BIOCAD - Overview
Exhibits142: JSC BIOCAD - Product / Service
Exhibits143: JSC BIOCAD - Key offerings
Exhibits144: LFB SA - Overview
Exhibits145: LFB SA - Product / Service
Exhibits146: LFB SA - Key offerings
Exhibits147: Novartis AG - Overview
Exhibits148: Novartis AG - Business segments
Exhibits149: Novartis AG - Key offerings
Exhibits150: Novartis AG - Segment focus
Exhibits151: Pfizer Inc. - Overview
Exhibits152: Pfizer Inc. - Product / Service
Exhibits153: Pfizer Inc. - Key news
Exhibits154: Pfizer Inc. - Key offerings
Exhibits155: Regeneron Pharmaceuticals Inc. - Overview
Exhibits156: Regeneron Pharmaceuticals Inc. - Product / Service
Exhibits157: Regeneron Pharmaceuticals Inc. - Key offerings
Exhibits158: Spectrum Pharmaceuticals Inc. - Overview
Exhibits159: Spectrum Pharmaceuticals Inc. - Product / Service
Exhibits160: Spectrum Pharmaceuticals Inc. - Key offerings
Exhibits161: TG Therapeutics Inc. - Overview
Exhibits162: TG Therapeutics Inc. - Product / Service
Exhibits163: TG Therapeutics Inc. - Key offerings
Exhibits164: Inclusions checklist
Exhibits165: Exclusions checklist
Exhibits166: Currency conversion rates for US$
Exhibits167: Research methodology
Exhibits168: Validation techniques employed for market sizing
Exhibits169: Information sources
Exhibits170: List of abbreviations